Synthesis of an Hsp70 inhibitor and its assessment of lysosomal membrane permeabilization

被引:4
|
作者
Park, Sang-Hyun [1 ]
Park, Sookil [1 ]
Shin, Injae [1 ]
机构
[1] Yonsei Univ, Dept Chem, Seoul 03722, South Korea
来源
STAR PROTOCOLS | 2021年 / 2卷 / 01期
基金
新加坡国家研究基金会;
关键词
APOPTOSIS;
D O I
10.1016/j.xpro.2021.100349
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Hsp70 inhibitors have great potential as chemical probes and anticancer agents. Thus, it is important to elucidate their modes of action on cancer cell death. This protocol describes a step-by-step process for the synthesis of apoptozole as an inhibitor of Hsp70, analysis of internalization of apoptozole into lysosomes, and assessment of lysosomal membrane permeabilization induced by apopto-zole. The current protocol can be used for detailed mechanistic studies of Hsp70 inhibitors and further substances targeting lysosomal proteins on cancer cell death.For complete information on the use and execution of this protocol, please refer to Park et al. (2018).
引用
收藏
页数:14
相关论文
共 50 条
  • [31] Evidence of a role for both anti-Hsp70 antibody and endothelial surface membrane Hsp70 in atherosclerosis
    Leng, Xue
    Wang, Xinxing
    Pang, Wei
    Zhan, Rui
    Zhang, Zhiqing
    Wang, Liqun
    Gao, Xiujie
    Qian, Lingjia
    CELL STRESS & CHAPERONES, 2013, 18 (04): : 483 - 493
  • [32] The Hsp70 inhibitor 2-phenylethynesulfonamide inhibits replication and carcinogenicity of Epstein–Barr virus by inhibiting the molecular chaperone function of Hsp70
    Huan Wang
    Lang Bu
    Chao Wang
    Yaqian Zhang
    Heng Zhou
    Xi Zhang
    Wei Guo
    Cong Long
    Deyin Guo
    Xiaoping Sun
    Cell Death & Disease, 9
  • [33] Efficacy of the HSP70 inhibitor PET-16 in multiple myeloma
    Bailey, Charvann K.
    Budina-Kolomets, Anna
    Murphy, Maureen E.
    Nefedova, Yulia
    CANCER BIOLOGY & THERAPY, 2015, 16 (09) : 1422 - 1426
  • [34] Antileukemic activity of the HSP70 inhibitor pifithrin-μ in acute leukemia
    Kaiser, M.
    Kuehnl, A.
    Reins, J.
    Fischer, S.
    Ortiz-Tanchez, J.
    Schlee, C.
    Mochmann, L. H.
    Heesch, S.
    Benlasfer, O.
    Hofmann, W-K
    Thiel, E.
    Baldus, C. D.
    BLOOD CANCER JOURNAL, 2011, 1 : e28 - e28
  • [35] Antileukemic activity of the HSP70 inhibitor pifithrin-μ in acute leukemia
    M Kaiser
    A Kühnl
    J Reins
    S Fischer
    J Ortiz-Tanchez
    C Schlee
    L H Mochmann
    S Heesch
    O Benlasfer
    W-K Hofmann
    E Thiel
    C D Baldus
    Blood Cancer Journal, 2011, 1 : e28 - e28
  • [36] Lysosomal rerouting of Hsp70 trafficking as a potential immune activating tool for targeting melanoma
    Juhasz, K.
    Nimmervoll, B.
    Thuenauer, R.
    Hesse, J.
    Haselgrubler, T.
    Horvath, I.
    Vigh, L.
    Hinterdorfer, P.
    Sonnleitner, A.
    Chtcheglova, L.
    Balogi, Z.
    FEBS JOURNAL, 2013, 280 : 210 - 211
  • [37] Autophagy of HSP70 and chelation of lysosomal iron in a non-redox-active form
    Kurz, Tino
    Brunk, Ulf T.
    AUTOPHAGY, 2009, 5 (01) : 93 - 95
  • [38] Characterization of the mechanism of action of a novel small molecule inhibitor of HSP70
    Balaburski, Gregor
    Leu, Julia I-Ju
    Andrake, Mark
    Hayik, Seth
    Beeharry, Neil
    Dunbrack, Roland
    Yen, Tim
    George, Donna L.
    Murphy, Maureen E.
    CANCER RESEARCH, 2012, 72
  • [39] A Modified HSP70 Inhibitor Shows Broad Activity as an Anticancer Agent
    Balaburski, Gregor M.
    Leu, Julia I. -Ju
    Beeharry, Neil
    Hayik, Seth
    Andrake, Mark D.
    Zhang, Gao
    Herlyn, Meenhard
    Villanueva, Jessie
    Dunbrack, Roland L., Jr.
    Yen, Tim
    George, Donna L.
    Murphy, Maureen E.
    MOLECULAR CANCER RESEARCH, 2013, 11 (03) : 219 - 229
  • [40] Lysosomal Rerouting of Hsp70 Trafficking as a Potential Immune Activating Tool for Targeting Melanoma
    Juhasz, Kata
    Thuenauer, Roland
    Spachinger, Andrea
    Duda, Erno
    Horvath, Ibolya
    Vigh, Laszlo
    Sonnleitner, Alois
    Balogi, Zsolt
    CURRENT PHARMACEUTICAL DESIGN, 2013, 19 (03) : 430 - 440